
REASONS FOR THE DEVELOPMENT OF ENDOMETRIAL HYPERPLASTIC PROCESSES IN WOMEN IN REPRODUCTIVE AGE (REVIEW)
Dustova Nigora Kakhramonovna, Kurbonova Gulnora Radzhabovna , Bukhara State Medical Institute named after Abu Ali ibn Sina, Uzbekistan,Abstract
Despite the progress made in the study of etiopathogenesis, new methods for diagnosing and treating endometrial hyperplasia, the problem of treating patients with this pathology still remains far from being solved. All this dictates the need to optimize the tactics of managing patients with endometrial hyperplasia in reproductive age, which should be aimed not only at creating adequate comprehensive approaches to predicting the development and recurrence of endometrial hyperplasia, but also at developing uniform protocols for managing patients with this pathology.
Keywords
Endometrial hyperplasia, abnormal uterine bleeding, hyperestrogenism, proliferation, apoptosis.
References
Al-Kaabi M, Noel K, Al-Rubai AJ. Evaluation of immunohistochemical expression of stem cell markers (NANOG and CD133) in normal, hyperplastic, and malignant endometrium. J Med Life. 2022 Jan;15(1):117-123. doi: 10.25122/jml-2021-0206.
Begum J, Samal R. A Clinicopathological Evaluation of Postmenopausal Bleeding and Its Correlation with Risk Factors for Developing Endometrial Hyperplasia and Cancer: A Hospital-Based Prospective Study. J Midlife Health. 2019 Oct-Dec;10(4):179-183. doi: 10.4103/jmh.JMH_136_18.
Behrouzi R, Barr CE, Crosbie EJ. HE4 as a Biomarker for Endometrial Cancer. Cancers (Basel). 2021 Sep 23;13(19):4764. doi: 10.3390/cancers13194764.
Catena U, Della Corte L, Raffone A, Travaglino A, Lucci Cordisco E, Teodorico E, Masciullo V, Bifulco G, Di Spiezio Sardo A, Scambia G, Fanfani F. Fertility-sparing treatment for endometrial cancer and atypical endometrial hyperplasia in patients with Lynch Syndrome: Molecular diagnosis after immunohistochemistry of MMR proteins. Front Med (Lausanne). 2022 Aug 25;9:948509. doi: 10.3389/fmed.2022.948509.
Chae-Kim J, Garg G, Gavrilova-Jordan L, Blake LE, Kim TT, Wu Q, Hayslip CC. Outcomes of women treated with progestin and metformin for atypical endometrial hyperplasia and early endometrial cancer: a systematic review and meta-analysis. Int J Gynecol Cancer. 2021 Dec;31(12):1499-1505. doi: 10.1136/ijgc-2021-002699.
Chekhoeva A. N., Gabaraev G. M., Baroeva M. D. Clinical and diagnostic aspects and therapeutic tactics of endometrial hyperplastic processes from modern positions (literature review) // Bulletin of new medical technologies. Electronic edition. 2019. No. 4.
Chen J, Cao D, Yang J, Yu M, Zhou H, Cheng N, Wang J, Zhang Y, Peng P, Shen K. Fertility-Sparing Treatment for Endometrial Cancer or Atypical Endometrial Hyperplasia Patients With Obesity. front oncol. 2022 Feb 18;12:812346. doi: 10.3389/fonc.2022.812346.
Chen J, Cheng Y, Fu W, Peng X, Sun X, Chen H, Chen X, Yu M. PPOS Protocol Effectively Improves the IVF Outcome Without Increasing the Recurrence Rate in Early Endometrioid Endometrial Cancer and Atypical Endometrial Hyperplasia Patients After Fertility Preserving Treatment . Front Med (Lausanne). 2021 Jul 27;8:581927. doi: 10.3389/fmed.2021.581927.
Clarke MA, Long BJ, Sherman ME, Lemens MA, Podratz KC, Hopkins MR, Ahlberg LJ, Mc Guire LJ, Laughlin-Tommaso SK, Bakkum-Gamez JN, Wentzensen N. Risk assessment of endometrial cancer and endometrial intraepithelial neoplasia in women with abnormal bleeding and implications for clinical management algorithms. Am J Obstet Gynecol. 2020 Oct;223(4):549.e1-549.e13. doi: 10.1016/j.ajog.2020.03.032.
Demakova N.A. Molecular and genetic characteristics of patients with endometrial hyperplasia and polyps // Scientific results of biomedical research. 2018. №2.
Ikhtiyarova, G.A., Aslonova, M.Zh., Kurbanova, Z.Sh., Kalimatova, D.M. (2021) Promising diagnostic tools for endometriosis given the pathogenic role of genetic factors. Russian Journal of Woman and Child Health, 4 (1), DOI: 10.32364/2618-8430-2021-4-1-12-16.
Lapina I.A., Dobrokhotova Yu.E., Ozolinya L.A., Chirvon T.G., Taranov V.V. An integrated approach to the management of patients with endometrial hyperplasia and metabolic syndrome // Gynecology. 2021. №1.
Luo L, Luo B, Zheng Y, Zhang H, Li J, Sidell N. Oral and intrauterine progestogens for atypical endometrial hyperplasia. Cochrane Database Syst Rev. 2018 Dec 4;12(12):CD009458. doi: 10.1002/14651858.CD009458.pub3.
Narzullaeva, N. S., Ixtiyarova, G. A., & Sh, B. A. (2022). Clinical and Immunologycal Aspecys of Leomioma with Endometritis. Central Asian Journal of Medical and Natural Science, 3(4), 301-305.
Narzullayeva, N. S. (2022). INNOVATIVE METHODS OF DIAGNOSIS AND TREATMENT IN WOMEN WITH INFERTILITY ASSOCIATED WITH UTERINE FIBROIDS. Journal of Pharmaceutical Negative Results, 3313-3321.
Narzulloeva, N. S. (2022). Uterine Myoma: Optimization of Management and Immunomodulating Therapy. INTERNATIONAL JOURNAL OF HEALTH SYSTEMS AND MEDICAL SCIENCES, 1(4), 284-289.Kaprin A.D., Starinsky V.V., Shakhzodova A.O. Malignant neoplasms in Russia in 2019 (morbidity and mortality). MNIOI them. PA Herzen - branch of the Federal State Budgetary Institution "NMITs Radiology" of the Ministry of Health of Russia, 2020; 252.
Nazirova Z.M. Modern possibilities of diagnosing proliferative processes of the endometrium // Economics and society. 2020. No. 4 (71).
Orazov M.R., Mikhaleva L.M., Mullina I.A. Prediction of recurrent endometrial hyperplasia // Difficult patient. 2021. No. 7.
Orazov M.R., Mikhaleva L.M., Mullina I.A., Leffad L.M. Pathogenesis of recurrent endometrial hyperplasia without atypia // Difficult patient. 2021. №6.
Oripova, F.Sh. Ikhtiyarova, G.A., & Davlatov, S.S. (2021). Pathomorphological characteristics of the vaginal mucosa in experimental notspecific vaginitis and various methods of treatment. International Journal of Pharmaceutical Research, 13(1), 761-765. doi: 10.31838/ijpr/2021.13.01.131Navruzova, N. O., Karshiyeva, E. E., Ikhtiyarova, G. A., Hikmatova, N. I., Olimova, N. I., & Muminova, N. K. (2021). Clinical and laboratory markers forecasting of cervical diseases and its prevention. Annals of the Romanian Society for Cell Biology, 25(4), 13098-13110. Retrieved from www.scopus.com.
Ponomarenko I.V., Demakova N.A., Altukhova O.B. Molecular mechanisms of development of endometrial hyperplastic processes // Actual problems of medicine. 2016. No. 19 (240).
Qurbonova, N. I., Khabibova, N. N., & Ikhtiyarova, G. A. (2020). Hygienic condition of the oral cavity and the level of hygienic knowledge of silk motor workers. European Journal of Molecular and Clinical Medicine, 7(3), 3027-3033. Retrieved from www.scopus.comOripova, F. S., Ikhtiyarova, G. A., Shukurlaev, K., & Khamdamova, M. T. (2021). New methods of correction of inflammatory diseases of the genitalia (clinical and experimental study). Annals of the Romanian Society for Cell Biology, 25(4), 1865-1872. Retrieved from www.scopus.com
Article Statistics
Downloads
Copyright License

This work is licensed under a Creative Commons Attribution 4.0 International License.